Back

Berger Montague investigates ADMA Biologics over potential fiduciary breaches

Verifying
  • Berger Montague opened an investigation into ADMA Biologics’ board and potential fiduciary-duty breaches.
  • ADMA’s ASCENIV product faced declining demand amid alleged channel-stuffing to drive revenue growth.
  • ADMA is headquartered in Ramsey, New Jersey, and trades on Nasdaq under ADMA.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.